Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Remo Guerrini

Showing results (211-220 of 220) with videos related to

Pageof 22
Sort By:
You have reached the last page of results.This site can display upto 220 results.
European Journal of Pharmacology|November 6, 2016
In vitro functional characterization of novel nociceptin/orphanin FQ receptor agonists in recombinant and native preparationsFederica Ferrari, Maria Camilla Cerlesi, Davide Malfacini, et al.
European Journal of Medicinal Chemistry|May 16, 2025
Identification of isoxazole-based TRPA1 inhibitors with analgesic effects in vivoValentina Albanese, Matilde Marini, Martina Tesi, et al.
Journal of Medicinal Chemistry|July 24, 2018
Conformational Propensity and Biological Studies of Proline Mutated LR Peptides Inhibiting Human Thymidylate Synthase and Ovarian Cancer Cell GrowthPuneet Saxena, Leda Severi, Matteo Santucci, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 20, 2015
Selective breeding for high anxiety introduces a synonymous SNP that increases neuropeptide S receptor activityDavid A Slattery, Roshan R Naik, Thomas Grund, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 29, 2011
Protein-protein interface-binding peptides inhibit the cancer therapy target human thymidylate synthaseDaniela Cardinale, Giambattista Guaitoli, Donatella Tondi, et al.
British Journal of Pharmacology|January 13, 2016
Nociceptin/orphanin FQ (N/OFQ) modulates immunopathology and airway hyperresponsiveness representing a novel target for the treatment of asthmaShailendra R Singh, Nikol Sullo, Maria Matteis, et al.
Journal of Medicinal Chemistry|May 17, 2021
Novel Mixed NOP/Opioid Receptor Peptide AgonistsSalvatore Pacifico, Valentina Albanese, Davide Illuminati, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 29, 2004
[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptorGiacomo Carrà, Anna Rizzi, Remo Guerrini, et al.
European Journal of Medicinal Chemistry|September 4, 2025
Identification of pyrazolo-piperidinone derivatives targeting YAP-TEAD interface 3 as anticancer agents through integrated virtual screening and mass spectrometry proteomicsLaura Scalvini, Lorenzo Tagliazucchi, Gian Marco Elisi, et al.
Elife|December 7, 2022
Destabilizers of the thymidylate synthase homodimer accelerate its proteasomal degradation and inhibit cancer growthLuca Costantino, Stefania Ferrari, Matteo Santucci, et al.
Pageof 22

Showing results (211-220 of 220) with videos related to

Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 220 results.
European Journal of Pharmacology|November 6, 2016
In vitro functional characterization of novel nociceptin/orphanin FQ receptor agonists in recombinant and native preparationsFederica Ferrari, Maria Camilla Cerlesi, Davide Malfacini, et al.
European Journal of Medicinal Chemistry|May 16, 2025
Identification of isoxazole-based TRPA1 inhibitors with analgesic effects in vivoValentina Albanese, Matilde Marini, Martina Tesi, et al.
Journal of Medicinal Chemistry|July 24, 2018
Conformational Propensity and Biological Studies of Proline Mutated LR Peptides Inhibiting Human Thymidylate Synthase and Ovarian Cancer Cell GrowthPuneet Saxena, Leda Severi, Matteo Santucci, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 20, 2015
Selective breeding for high anxiety introduces a synonymous SNP that increases neuropeptide S receptor activityDavid A Slattery, Roshan R Naik, Thomas Grund, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 29, 2011
Protein-protein interface-binding peptides inhibit the cancer therapy target human thymidylate synthaseDaniela Cardinale, Giambattista Guaitoli, Donatella Tondi, et al.
British Journal of Pharmacology|January 13, 2016
Nociceptin/orphanin FQ (N/OFQ) modulates immunopathology and airway hyperresponsiveness representing a novel target for the treatment of asthmaShailendra R Singh, Nikol Sullo, Maria Matteis, et al.
Journal of Medicinal Chemistry|May 17, 2021
Novel Mixed NOP/Opioid Receptor Peptide AgonistsSalvatore Pacifico, Valentina Albanese, Davide Illuminati, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 29, 2004
[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptorGiacomo Carrà, Anna Rizzi, Remo Guerrini, et al.
European Journal of Medicinal Chemistry|September 4, 2025
Identification of pyrazolo-piperidinone derivatives targeting YAP-TEAD interface 3 as anticancer agents through integrated virtual screening and mass spectrometry proteomicsLaura Scalvini, Lorenzo Tagliazucchi, Gian Marco Elisi, et al.
Elife|December 7, 2022
Destabilizers of the thymidylate synthase homodimer accelerate its proteasomal degradation and inhibit cancer growthLuca Costantino, Stefania Ferrari, Matteo Santucci, et al.
Pageof 22